Carbohydrate antigen 19 - 9 (CA19-9), which is the most widely used tumor marker in diagnosis of CHOL, is higher in the high ACSL4 expression group, though the P-value was not statistically significant (Table 1). This evidence concerns the gene ACSL4 and neoplasm.